HMGCR 抗体 (AA 268-842) (Fluoro647)
Our Local Distributor
北京 101111
Quick Overview for HMGCR 抗体 (AA 268-842) (Fluoro647) (ABIN7964865)
抗原
See all HMGCR 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 268-842
-
原理
- Anti-HMGCR Antibody Fluoro647 Conjugated
-
交叉反应 (详细)
- No cross-reactivity with other proteins.
-
纯化方法
- Immunogen affinity purified.
-
免疫原
- E.coli-derived human HMGCR recombinant protein (Position: H268-V842).
-
亚型
- IgG
-
-
-
-
应用备注
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
有效期
- 12 months
-
-
- HMGCR (3-Hydroxy-3-Methylglutaryl-CoA Reductase (HMGCR))
-
别名
- HMGCR
-
背景
-
Background: HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Gene Full Name: 3-hydroxy-3-methylglutaryl-CoA reductase
-
基因ID
- 3156
-
UniProt
- P04035
-
途径
- AMPK Signaling, Negative Regulation of Hormone Secretion, Regulation of Lipid Metabolism by PPARalpha
抗原
-